Company / Cash per Share
Perspective Therapeutics, Inc. Cash per Share History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.39
FY2022
5-year range
$0.03 / $0.39
FY2018-FY2022
Trend
+1034.4%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share changed +1034% YoY in FY2022, a notable deviation from the 9-year average annual change of +122%.
Based on SEC 10-K filings.
0.39 in FY2022 with a 5-year CAGR of +32.9%.
Improved from $0.08 to $0.39 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +104.3%
- 5-Year CAGR
- +32.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, cash per share increased 1034.4% year-over-year.
- Lowest cash per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 5.43 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $0.39 | +1034.4% |
| FY2021 | $0.03 | -56.1% |
| FY2020 | $0.08 | +71.2% |
| FY2019 | $0.05 | -57.2% |
| FY2018 | $0.11 | +13.5% |
| FY2017 | $0.10 | -48.6% |
| FY2016 | $0.18 | +164.8% |
| FY2015 | $0.07 | -9.6% |
| FY2014 | $0.08 | -10.6% |
| FY2013 | $0.09 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026